机构地区:[1]第四军医大学附属西京医院骨与软组织肿瘤科,西安710032
出 处:《中华骨科杂志》2014年第4期460-465,共6页Chinese Journal of Orthopaedics
摘 要:目的探讨采用经“Y”型软骨截骨髋臼挽救术治疗儿童和青少年TypeⅡ型骨盆尤文肉瘤患者的生存率及疗效。方法回顾性分析2001年1月至2010年10月采用经髋臼“Y”型软骨截骨、异体髋臼复合钢板重建、髋臼挽救术治疗8例骨盆Typell型尤文肉瘤患者资料,男6例,女2例;手术时年龄7-16岁,平均12.7岁。其中3例肿瘤位于“Y”型软骨上方,4例位于“Y”型软骨前下方,1例位于“Y”型软骨后下方;均为局部肿瘤,无远处转移。所有患者均行x线、CT、MRI等影像学检查,并经病理学诊断证实。化疗采用顺铂(CDP)、阿霉素(ADM)和异环磷酰胺(IFO)方案。所有患者术前均接受一个循环的新辅助化疗(即IFO-ADM+CDP-IFO),术后均接受三个循环的IFO-ADM+CDP-IFO和局部放疗;放射治疗覆盖时间内的化学治疗同期进行。3例采用传统切除重建手术,5例借助于计算机辅助导航系统接受了肿瘤的精确切除和重建手术。结果依据实体瘤疗效评价标准对新辅助化疗进行评价,结果显示1例为完全响应,6例为部分响应,1例为痈隋平稳。无一例患者被诊断为疾病进展。术后8例患者均获得随访,随访时间为12-72个月,中位随访时间为37.8个月。7例患者无瘤生存时间为24-60个月,平均39个月。术后24个月1例患者死于肿瘤转移。两年生存率为100%,五年生存率为87.5%(7/8)。肌肉骨骼肿瘤协会(MsTs)评分为18-27分,平均25_4分。国际保肢协会影像学评分为76%-94%,平均90.1%。结论采用经髋臼“Y”型软骨截骨、异体髋臼复合钢板重建、髋臼挽救术治疗儿童和青少年TypeⅡ型骨盆尤文肉瘤,术后患者生存率高,可恢复患者的肢体功能。“Y”型软骨有可能是抵御肿瘤侵袭的天然屏障。Objective To analyze the survival rate and functional outcomes after osteotomy through acetabular triradiate cartilage for surgical management of type Ⅱ pelvic Ewing sarcoma. Methods Data of 8 patients (male: 6; female: 2) with type Ⅱ pelvic Ewing sarcoma receiving treatment in our department from January 200l to October 2010 were retrospectively analyzed. The mean age was 12.7 years (range, 7-16 years). The tumors were located above, anteiro-inferior, and posterior-inferior to triradi-ate cartilage in 3, 4, and 1 case, respectively. All tumors were localized and no metastasis was found. All patients received X-ray film, CT scan, and MRI. The diagnosis was determined by biopsy. All patients had undergone neoadjuvant chemotherapy and ra- diotherapy (post operation). All patients received 1 cycle of IFO-ADM+CDP-IFO and 2 cycles of same reagents before and after surgery. All patients received radio-therapy after surgery. In these consecutive patients, three received conventional surgery and another 5 were operated with the help of computer-assisted surgical navigation system. Results According to response evalua-tiong criteria in solid tumors (RECIST), CR was in 1 case, PR in 6 cases and SD in 1 case. No patient was recorded as PD. All pa-tients were followed up for 12 to 72 months (mean, 37.8 months). There were 7 patients surviving from 24 to 60 months (mean, 39 months) with disease-free survival. One patient died of metastasis at 24 months postoperatively. The cumulative survival rate at 2 and 5 years were 100% and 87.5%, respectively. The MSTS score ranged from 18 to 27 (mean, 25.4) and radiological score of In- ternational Society of Limb Salvage (ISOLS) ranged from 76% to 94% (mean, 90.1%). Conclusion Osteotomy through acetabular triradiate cartilage in combination with allograft reconstruction can maximally restore the hip function and increase the survival rate. The triradiate cartilage may be a natural barrier to orevent tumor invasion.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...